The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N07 | Other nervous system drugs | |
| 3 | N07A | Parasympathomimetics | |
| 4 | N07AX | Other parasympathomimetics |
| Code | Title | |
|---|---|---|
| N07AX01 | Pilocarpine | |
| N07AX02 | Choline alfoscerate | |
| N07AX03 |
| Active Ingredient | Description | |
|---|---|---|
| Cevimeline |
Cevimeline is a cholinergic agonist which binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands and increase tone of the smooth muscle in the gastrointestinal and urinary tracts. |
|
| Choline alfoscerate |
|
|
| Pilocarpine |
Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. Pilocarpine, in appropriate dosage, can increase secretion by exocrine glands such as the sweat, salivary, lacrimal, gastric, pancreatic and intestinal glands and the mucous cells of the respiratory tract. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EVOXAC Capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| SALAGEN Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
